Wednesday, December 26th, 2012
The FDA has sent a warning letter to 350 medical practices who may have purchased counterfeit Botox from a Canadian supplier. From NBC News.com:
The Food and Drug Administration said in a letter sent last month, a letter released publicly last week, that batches of the wrinkle treatment shipped by suppliers owned by pharmacy Canada Drugs have not been approved by the FDA and that the agency cannot assure their effectiveness or their safety.
The FDA said Canada Drugs was previously tied to shipping unapproved and counterfeit cancer drugs.
The agency warned doctors about buying drugs from sources other than licensed U.S. pharmacies. It is the fifth warning the agency has made this year about foreign suppliers providing unapproved drugs.
I often get faxes from various pharmacies offering Botox and other injectable products at prices cheaper than I get from the company directly. The offers are enticing, but I’ve never taken them up, mainly because I’ve been afraid that the product isn’t genuine. All plastic surgeons and dermatologists should be aware of this FDA warning, especially since these “Botox at 50% off!” faxes arrive quite frequently.